2018 Fall Forum: Health and the Environment in North Carolina

Duke University Environmental Health Scholars Program

David Peden

M.D., M.S.
Andrews Distinguished Professor of Pediatrics
Senior Associate Dean for Translational Research
Director, Center for Environmental Medicine, Asthma and Lung Biology
Chief, Division of Allergy Immunology and Rheumatology, Department of Pediatrics
University of North Carolina at Chapel Hill School of Medicine

Dr. Peden is the Harry S. Andrews Professor of Pediatrics, Medicine and Microbiology/Immunology and serves as senior associate dean for translational research, chief of the Division of Pediatric Allergy, Immunology and Rheumatology, and director of the Center for Environmental Medicine, Asthma and Lung Biology for the University of North Carolina (UNC) School of Medicine. He is board certified in pediatrics, allergy and immunology and clinical laboratory immunology.

Dr. Peden’s group has extensive expertise in evaluating persons for asthma, allergies and lung disease using spirometry, methacholine challenge, analysis of induced sputum and allergen skin testing. He is currently principal investigator for over $5 million of federally funded research grants for work including clinical investigations of the effect of challenge and exposure to environmental agents including ozone,endotoxin, concentrated air particulates and wood smoke particles. His current projects include assessing the effect of gamma tocopherol on the effect of ozone and wood smoke in heathy and asthmatic volunteers, and phase I/II studies focused on novel treatments for airway clearance in asthma in conjunction with the Marsico Lung Institute.

He serves as a member of the executive and steering committees for the National Heart Lung and Blood Institute PreCISE program for testing precision medicine approaches for novel agents in asthma as part of the UNC team from the Collaborative Studies Coordinating Center from the School of Public Health, as a key investigator in the National Center for Advancing Translational Sciences-funded Biomedical Data Translator program in conjunction with the Renaissance Computing Institute, and is site principal investigator for the National Institute of Allergy and Infectious Diseases-funded Immune Tolerance Network study CATNIP, which examines the effect of anti-TSLP on response to cat-allergic persons to cat immunotherapy. He is also medical director of the National Science Foundation Nanosystems Engineering Research Center for Advanced Self-Sustaining Integrated Sensor Technologies based at North Carolina State University, which is focused on developing and testing wearable sensors for physiologic and environmental exposure data.

Dr. Peden serves on National Institutes of Health grant review committees, is a regular member of the Environmental Protection Agency advisory committees for sulfur oxides and particulate matter, and is chair of the U.S. Food and Drug Administration’s Allergenic Products Advisory Committee. He is an associate editor for the Journal of Allergy and Clinical Immunology and is editor-in-chief of Current Allergy and Asthma Reports.

He received his M.D. and M.S. in science and pharmacology and toxicology degrees from WestVirginia University and completed his residency and chief residency in pediatrics at West Virginia University Medical Center. His fellowship training in allergy andimmunology was completed at the National Institutes of Health’s National Institute of Allergy and Infectious Diseases.